NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1122, doi. 10.1007/s00262-005-0089-3
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2006 AND VI 55 AND IP 9
Results: 13
1
2
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146–154 peptide.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1033, doi. 10.1007/s00262-005-0090-x
- By:
- Publication type:
- Article
3
Inhibition of nuclear factor kappa B (NFκB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1052, doi. 10.1007/s00262-005-0093-7
- By:
- Publication type:
- Article
4
CD4(+)CD25<sup>high</sup> regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1064, doi. 10.1007/s00262-005-0092-8
- By:
- Publication type:
- Article
5
Characterization of the γδ T cell response to acute leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1072, doi. 10.1007/s00262-005-0094-6
- By:
- Publication type:
- Article
6
Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4<sup>+</sup> T cell dependent and antibody mediated.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1081, doi. 10.1007/s00262-005-0096-4
- By:
- Publication type:
- Article
7
Growth inhibition of breast cancer cell lines overexpressing Her2/neu by a novel internalized fully human Fab antibody fragment.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1091, doi. 10.1007/s00262-005-0100-z
- By:
- Publication type:
- Article
8
Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1043, doi. 10.1007/s00262-005-0101-y
- By:
- Publication type:
- Article
9
Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1100, doi. 10.1007/s00262-005-0099-1
- By:
- Publication type:
- Article
10
The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1111, doi. 10.1007/s00262-005-0105-7
- By:
- Publication type:
- Article
11
A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1132, doi. 10.1007/s00262-005-0098-2
- By:
- Publication type:
- Article
12
T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1142, doi. 10.1007/s00262-005-0103-9
- By:
- Publication type:
- Article
13
Effect of interleukin-18 on metastasis of mouse osteosarcoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 9, p. 1151, doi. 10.1007/s00262-005-0097-3
- By:
- Publication type:
- Article